Evidence explainerVitamin E (natural d-alpha vs synthetic dl-alpha tocopherol)
Vitamin E for Your Heart? Three Big Trials Found No Benefit, and Some Found Harm
Vitamin E looked promising in observational studies. Then more than 60,000 people took it in long randomized trials. Here is what happened.
Key takeaways
- HOPE (9,541 high-risk adults, 400 IU/day natural vitamin E) found no change in major cardiovascular events (RR 1.04) and more heart failure (RR 1.13) [2].
- The Women's Health Study (39,876 healthy women, 600 IU every other day for about 10 years) found no significant drop in major cardiovascular events (RR 0.93) [3].
- The Physicians' Health Study II (14,641 men, 400 IU every other day for 8 years) found no effect on major events (HR 1.01) and more hemorrhagic stroke (HR 1.74) [4].
- In SELECT, 400 IU/day of synthetic vitamin E raised prostate cancer by 17% in healthy men [5].
- A meta-analysis of 19 trials linked 400 IU/day or more to slightly higher mortality [6].
The evidence, graded
Pulled from our monograph evidence tables. Grades follow our evidence-grading policy.
- No effectNo effectMajor heart and blood-vessel events in high-risk adults (HOPE / HOPE-TOO)No difference in major cardiovascular events (RR 1.04; 95% CI 0.96-1.14), cancer incidence or cancer deaths. Heart failure (RR 1.13) and hospitalization for heart failure (RR 1.21) were higher with vitamin E.
- No effectNo effectMajor heart and blood-vessel events in healthy women (WHS)Major cardiovascular events were not significantly reduced (RR 0.93; 95% CI 0.82-1.05), nor were total cancer or total mortality. Cardiovascular death was 24% lower (RR 0.76), a secondary finding.
- No effectNo effectMajor heart and blood-vessel events in men 50+ (PHS II)No effect on major cardiovascular events (HR 1.01; 95% CI 0.90-1.13) or total mortality, but a higher risk of hemorrhagic stroke (HR 1.74; 95% CI 1.04-2.91).
- Grade BImprovedProstate outcome in healthy men (SELECT extended follow-up)Prostate cancer was 17% more common with vitamin E than placebo (HR 1.17; 99% CI 1.004-1.36): 620 vs 529 men, an absolute increase of 1.6 per 1000 person-years.
- Grade CImprovedAll-cause mortality with high-dosage vitamin ETrials of ≥400 IU/d showed 39 more deaths per 10,000 persons (95% CI 3 to 74); low-dosage trials showed no increase. Risk rose with dosages above 150 IU/d.
Why people hoped it would work
Vitamin E is a fat-soluble antioxidant, and observational studies suggested that people with high vitamin E intakes from food or supplements had fewer heart problems [3][1]. Those studies cannot separate the vitamin from the kind of person who takes it, so the long randomized trials below were the real test.
HOPE: high-risk adults, 400 IU a day
HOPE enrolled 9,541 adults aged at least 55 with vascular disease or diabetes, and gave 400 IU/day of natural-source vitamin E or placebo; the HOPE-TOO extension brought median follow-up to 7.0 years [2].
Major cardiovascular events were no lower (21.5% vs 20.6%; RR 1.04), and cancer rates did not differ [2]. Heart failure was more common with vitamin E (RR 1.13), as were hospital stays for heart failure (RR 1.21) [2]. ODS calls the HOPE trials compelling evidence that these doses do not reduce serious cardiovascular events in men and women over 50 with heart disease or diabetes [1].
Women's Health Study: healthy women, 10 years
In 39,876 healthy US women aged 45 and older, 600 IU of natural-source vitamin E on alternate days for an average of 10.1 years gave a non-significant 7% drop in major cardiovascular events (RR 0.93) [3]. Heart attack and stroke were unchanged, and total cancer did not differ [3].
One secondary result stood out: cardiovascular deaths were 24% lower (RR 0.76) [3]. With the main outcome flat, the authors concluded the data do not support vitamin E for these purposes in healthy women [3].
Physicians' Health Study II: men over 50
The trial gave 14,641 US male physicians aged 50 and older 400 IU of vitamin E every other day, vitamin C, both or placebo, for a mean of 8 years [4]. Vitamin E had no effect on major cardiovascular events (HR 1.01), heart attacks or stroke overall [4].
It was linked to more hemorrhagic stroke (HR 1.74) [4]. ODS notes that most of these physicians also took aspirin, so the finding may reflect a combined bleeding tendency [1].
The harm signals in one place
None of these is proof on its own, but together they explain why ODS frames high-dose vitamin E as a safety question. The signals so far:
- Heart failure: RR 1.13 in HOPE, a secondary outcome [2].
- Hemorrhagic stroke: HR 1.74 in the Physicians' Health Study II [4].
- Prostate cancer: 620 vs 529 cases with 400 IU/day of synthetic vitamin E in SELECT (HR 1.17), in 34,887 men [5].
- Mortality: 39 more deaths per 10,000 people in trials of 400 IU/day or more, across 19 trials; the authors note those trials were often small and in people with chronic diseases [6].
Quick answers
Did natural vitamin E do better than synthetic in these trials?
HOPE and the Women's Health Study used natural-source vitamin E and found no reduction in major cardiovascular events [2][3]. SELECT used synthetic vitamin E [5]. For the label math, see 400 IU in mg, natural vs synthetic.
How does my multivitamin compare with the trial doses?
The trials tested 400 to 600 IU [2][3][4], which is about 180 to 402 mg depending on the form [1]. The adult RDA is 15 mg, so compare the mg on your label with both numbers [1].
Should I stop vitamin E before surgery?
High-dose vitamin E may raise bleeding risk, especially with blood thinners [1]. Tell your surgeon and clinician about every supplement you take.
Keep reading
Full monographs
Related articles
- 400 IU of Vitamin E Is Either 268 mg or 180 mg. The "d" or "dl" on the Label Decides
- B12 After 50 and on Metformin: Why Levels Drop, and What the Trials Say About Fixing Them
- Berberine Side Effects and Drug Interactions: The Liver-Enzyme Problem Nobody Mentions
- Berberine, “Nature’s Ozempic”: What the Trials Actually Show (Hint: About 2 Pounds)
Browse the full Supplement & Nutrient Encyclopedia or all supplement articles.
References
- [1]Vitamin E: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements, 2021.
- [2]Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA, 2005.
- [3]Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA, 2005.
- [4]Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA, 2008.
- [5]Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 2011.
- [6]Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med, 2005.
